Remdesivir
-
UK trials remdesivir treatment for CoVID-19 as UK PM aide row rages on
India | May 26, 2020, 10:37 PM ISTThe UK government on Tuesday confirmed the launch of a new trial for selected coronavirus patients of remdesivir, a drug which is believed to shorten the recovery time from COVID-19. “This is probably the biggest step forward since the coronavirus crisis began,” UK Health Secretary Matt Hancock announced at the daily Downing Street briefing.
-
Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug remdesivir
Business | May 13, 2020, 11:43 AM ISTHomegrown pharma major Cipla Ltd on Wednesday said it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distribution of investigational drug remdesivir, a potential therapy for COVID-19.
-
Hetero inks licensing agreement with Gilead for manufacturing, distribution of remdesivir
Business | May 13, 2020, 11:37 AM ISTDomestic pharma major Hetero on Wednesday said it has entered into a licensing agreement with Gilead Sciences Inc for manufacturing and distribution of remdesivir, a potential therapy for COVID-19.
-
Remdesivir to be produced in India as Gilead signs agreement with Cipla, Jubilant Life
Business | May 13, 2020, 10:09 AM ISTFive Indian companies including Cipla and Jubilant Life Sciences have signed an agreement with US drugmaker Gilead for the production of Remdesivir, which is leading the pack for drugs that are considered as a potential treatment for coronavirus. As per the agreement, the drug Remdesivir will be manufactured for distribution in 127 countries.
-
Donald Trump approves Gilead's remdesivir to treat COVID-19 patients
News | May 02, 2020, 11:30 AM ISTThe Food and Drug Administration on Friday allowed the emergency use of Gilead's remdesivir that appears to help some COVID-19 patients recover faster, a milestone in the global search for effective therapies against the coronavirus.